Neda Bernasconi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Neda Bernasconi has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
Andrea Bernasconi
McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
15 shared publicationsBoris C. Bernhardt
From the Neuroimaging of Epilepsy Laboratory (B.C.B., F.F., M.L., B.C., A.B., N.B.) and Multimodal Imaging and Connectome Analysis Laboratory (B.C.B.), McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Canada; Department of Bioengineering and Electrical and Systems Engineering (S.G., D.S.B.), University of Pennsylvania, Philadelphia; and York Neuroimaging Center (E.J., J.S.), University of York, UK
12 shared publications- Andrea Bernasconi
Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute and Hospital McGill University Montreal Quebec Canada
10 shared publications - Boris C. Bernhardt
McConnell Brain Imaging Centre (BIC), Montréal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada
10 shared publications Benoit Caldairou
Neuroimaging of Epilepsy Laboratory Montreal Neurological Institute, McGill University Montreal Quebec Canada
8 shared publicationsFatemeh Fadaie
Neuroimaging of Epilepsy Laboratory, McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
6 shared publications
Latest Publications
- Open Access
Use of artificial intelligence in magnetic resonance imaging across the epileptic patient's journey: A meta‐analysis of four clinical applications
Objective: The application of artificial intelligence/machine learning (AI/ML) to magnetic resonance imaging (MRI) promises to enhance and support clinical decision‐making in epilepsy. However, there currently lacks an appropriate assessment of clinical utility and study rigor of current AI/ML‐driven models that are targeted toward supporting decision‐making within the clinical workup in epilepsy. Methods: We systematically reviewed and examined the ability of current AI/ML‐driven models in MRI across four main applications within the clinical workup(s) for epilepsy: (1) diagnosis, (2) temporal lobe epilepsy lateralization, (3) lesion (focal cortical dysplasia) localization, and (4) postsurgical outcome prediction. We additionally assessed the risk of bias for each study model. Studies that employed AI/ML classification models trained on any MRI modality or sequence type were selected for qualitative assessment; those reporting accuracy rates were subsequently included in the meta‐analysis. Results: Of 3227 searched articles, we identified 159 studies ( n = 26 732 participants) for qualitative evaluation and 127 studies ( n = 20 456) for inclusion in the meta‐analysis. Our results reveal that AI/ML on MRI could accurately distinguish epilepsy patients from healthy controls (overall accuracy = .87, 95% confidence interval [CI] = .85–.89), lateralize temporal lobe epilepsy (.90, 95% CI = .87–.93), localize epileptogenic lesions (.82, 95% CI = .74–.87), and predict postsurgical seizure freedom (.83, 95% CI = .78–.87). However, systematic assessment indicated a very high risk of bias in the literature, suggestive of overly optimistic performance estimates. Significance: Although our results support overall high accuracy of AI/ML models in epilepsy diagnostics and prognostics, the literature remains susceptible to bias in participant recruitment and validation methods. Furthermore, most models were limited by study architecture that demands strict adherence to nonstandard, highly specific data acquisition and processing protocols that cannot be easily deployed for clinical implementation. We encourage closer interdisciplinary collaboration between clinical and scientific groups to improve validation studies, and outline suggested recommendations for future study design, analysis, and reporting.
Open AccessUse of artificial intelligence in magnetic resonance imaging across the epileptic patient's journey: A meta‐analysis of four clinical applications
Objective: The application of artificial intelligence/machine learning (AI/ML) to magnetic resonance imaging (MRI) promises to enhance and support clinical decision‐making in epilepsy. However, there currently lacks an appropriate assessment of clinical utility and study rigor of current AI/ML‐driven models that are targeted toward supporting decision‐making within the clinical workup in epilepsy. Methods: We systematically reviewed and examined the ability of current AI/ML‐driven models in MRI across four main applications within the clinical workup(s) for epilepsy: (1) diagnosis, (2) temporal lobe epilepsy lateralization, (3) lesion (focal cortical dysplasia) localization, and (4) postsurgical outcome prediction. We additionally assessed the risk of bias for each study model. Studies that employed AI/ML classification models trained on any MRI modality or sequence type were selected for qualitative assessment; those reporting accuracy rates were subsequently included in the meta‐analysis. Results: Of 3227 searched articles, we identified 159 studies ( n = 26 732 participants) for qualitative evaluation and 127 studies ( n = 20 456) for inclusion in the meta‐analysis. Our results reveal that AI/ML on MRI could accurately distinguish epilepsy patients from healthy controls (overall accuracy = .87, 95% confidence interval [CI] = .85–.89), lateralize temporal lobe epilepsy (.90, 95% CI = .87–.93), localize epileptogenic lesions (.82, 95% CI = .74–.87), and predict postsurgical seizure freedom (.83, 95% CI = .78–.87). However, systematic assessment indicated a very high risk of bias in the literature, suggestive of overly optimistic performance estimates. Significance: Although our results support overall high accuracy of AI/ML models in epilepsy diagnostics and prognostics, the literature remains susceptible to bias in participant recruitment and validation methods. Furthermore, most models were limited by study architecture that demands strict adherence to nonstandard, highly specific data acquisition and processing protocols that cannot be easily deployed for clinical implementation. We encourage closer interdisciplinary collaboration between clinical and scientific groups to improve validation studies, and outline suggested recommendations for future study design, analysis, and reporting.
- 23 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (6) , e213688
Changes in Gray Matter Morphology and White Matter Microstructure Across the Adult Lifespan in People With Temporal Lobe Epilepsy
Temporal lobe epilepsy (TLE) is commonly associated with mesiotemporal pathology and widespread alterations of gray and white matter structures. Evidence supports a progressive condition, although the temporal evolution of TLE is poorly defined. In this ENIGMA-Epilepsy study, we aim to investigate structural alterations in gray and white matter across the adult lifespan in patients with TLE by charting both gray and white matter changes and explore the covariance of age-related alterations in both compartments. Mega-analysis of parcellated T1-weighted and diffusion MRI data across 18 international sites for patients with TLE was compared against healthy controls. We combined median-age split groupwise comparisons with cross-sectional sliding age-window analyses to explore gray (cortical thickness, subcortical volume) and white matter microstructure (fractional anisotropy, mean diffusivity) age-related changes. Five-year range age windows were constructed from mean z scores of all patients. Covariance analyses examined the coupled correlations of gray and white matter lifespan curves for each region. We studied 769 patients with TLE and 885 healthy controls across an age range of 17-73 years. Robust (pFDR < 0.05) gray matter thickness/volume decline (d < -0.20) was seen across a broad cortico-subcortical territory, extending beyond the mesiotemporal lobe throughout the adult lifespan in patients with TLE. White matter changes were also widespread across multiple fiber tracts with peak effects in temporolimbic fibers in fractional anisotropy (d < -0.3, pFDR < 0.05) and mean diffusivity measures (d > 0.3, pFDR < 0.05). Changes spanned the adult time window and effects exceeded typical aging-related processes in patients at the level of cortical thickness, subcortical volume, and diffusion measures, particularly in patients older than 55 years. Covariance analyses revealed strong associations across multiple white matter tracts, subcortical structures, and cortical regions within and beyond the temporolimbic system. This study highlights that patients with TLE exhibit more pronounced and widespread gray and white matter atrophy across the lifespan. The cross-sectional nature of our study limits definitive conclusions on whether the atrophy shown is progressive but emphasizes the importance of prompt diagnosis and intervention in patients. Collectively, our results motivate future longitudinal studies to clarify consequences of drug-resistant epilepsy.
- 23 September 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (6) , e213688
Changes in Gray Matter Morphology and White Matter Microstructure Across the Adult Lifespan in People With Temporal Lobe Epilepsy
Temporal lobe epilepsy (TLE) is commonly associated with mesiotemporal pathology and widespread alterations of gray and white matter structures. Evidence supports a progressive condition, although the temporal evolution of TLE is poorly defined. In this ENIGMA-Epilepsy study, we aim to investigate structural alterations in gray and white matter across the adult lifespan in patients with TLE by charting both gray and white matter changes and explore the covariance of age-related alterations in both compartments. Mega-analysis of parcellated T1-weighted and diffusion MRI data across 18 international sites for patients with TLE was compared against healthy controls. We combined median-age split groupwise comparisons with cross-sectional sliding age-window analyses to explore gray (cortical thickness, subcortical volume) and white matter microstructure (fractional anisotropy, mean diffusivity) age-related changes. Five-year range age windows were constructed from mean z scores of all patients. Covariance analyses examined the coupled correlations of gray and white matter lifespan curves for each region. We studied 769 patients with TLE and 885 healthy controls across an age range of 17-73 years. Robust (pFDR < 0.05) gray matter thickness/volume decline (d < -0.20) was seen across a broad cortico-subcortical territory, extending beyond the mesiotemporal lobe throughout the adult lifespan in patients with TLE. White matter changes were also widespread across multiple fiber tracts with peak effects in temporolimbic fibers in fractional anisotropy (d < -0.3, pFDR < 0.05) and mean diffusivity measures (d > 0.3, pFDR < 0.05). Changes spanned the adult time window and effects exceeded typical aging-related processes in patients at the level of cortical thickness, subcortical volume, and diffusion measures, particularly in patients older than 55 years. Covariance analyses revealed strong associations across multiple white matter tracts, subcortical structures, and cortical regions within and beyond the temporolimbic system. This study highlights that patients with TLE exhibit more pronounced and widespread gray and white matter atrophy across the lifespan. The cross-sectional nature of our study limits definitive conclusions on whether the atrophy shown is progressive but emphasizes the importance of prompt diagnosis and intervention in patients. Collectively, our results motivate future longitudinal studies to clarify consequences of drug-resistant epilepsy.
- Open Access
MRI ‐negative epilepsy: A systematic review and meta‐analysis
Objective: Drug‐resistant focal epilepsy is commonly dichotomized based on magnetic resonance imaging (MRI) lesion visibility into positive (MRI‐pos) and negative (MRI‐neg). Yet, the criteria used to ascribe such categorization are variable. We used a systematic review and meta‐analysis to synthesize evidence for the designation of MRI‐neg status. Methods: In accordance with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines, the systematic review (1990–2025) across Embase, Cochrane, and Medline databases identified cohorts with MRI‐neg epilepsy. Unsupervised clustering stratified studies based on co‐occurrence of imaging modalities. Within identified classes, we assessed the consistency of reporting MRI parameters, rater expertise, post‐processing, and stereo–electroencephalography (SEEG). Meta‐analyses evaluated the effects of post‐processing on diagnostic yield and MRI‐neg status on post‐surgical outcome. Results: We screened 2622 records and assessed the eligibility of 448 full‐text articles, 246 of which met the inclusion criteria for systematic review: 108 (44%) provided data only on MRI‐neg and 138 (56%) on mixed adult cohorts, for a total of 10.463 MRI‐neg and 7436 MRI‐pos patients. Compared to MRI‐pos, MRI‐neg patients underwent SEEG more frequently (75% vs 54%, p < 0.05), underwent surgery less frequently (73% vs 84%; odds ratio [OR] = 1.14, p < 0.001), and had less favorable outcomes (61% vs 72%, p < 0.05). Clustering identified three classes: MRI‐dominant , typified by consistent reporting of MRI parameters (ORs >3.11, p < 0.001), rater‐expertise (ORs >9.94, p < 0.001), and post‐processing (ORs >3.38, p < 0.03) , as opposed to Limited‐MRI (χ 2 = 41.08, p < 0.001); MRI‐and‐nuclear‐imaging class was typified by use of SEEG (ORs >3.33, p < 0.02). Meta‐analyses showed a 39% gain in diagnostic yield after post‐processing (11.10, 95% confidence interval [CI] 7.45–16.53) and a higher proportion of favorable surgical outcome in MRI‐pos compared to MRI‐neg (75% vs 58%; χ 2 = 19.10, p < 0.001). Time‐based sensitivity analyses did not affect results. Significance: The designation of MRI‐neg is ambiguous, with most studies lacking details on imaging parameters and reader expertise. Given a 39% gain in diagnostic yield, MRI post‐processing should be performed systematically as part of a modern multimodal approach to epilepsy surgery before ascribing MRI‐neg status.
Open AccessMRI ‐negative epilepsy: A systematic review and meta‐analysis
Objective: Drug‐resistant focal epilepsy is commonly dichotomized based on magnetic resonance imaging (MRI) lesion visibility into positive (MRI‐pos) and negative (MRI‐neg). Yet, the criteria used to ascribe such categorization are variable. We used a systematic review and meta‐analysis to synthesize evidence for the designation of MRI‐neg status. Methods: In accordance with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines, the systematic review (1990–2025) across Embase, Cochrane, and Medline databases identified cohorts with MRI‐neg epilepsy. Unsupervised clustering stratified studies based on co‐occurrence of imaging modalities. Within identified classes, we assessed the consistency of reporting MRI parameters, rater expertise, post‐processing, and stereo–electroencephalography (SEEG). Meta‐analyses evaluated the effects of post‐processing on diagnostic yield and MRI‐neg status on post‐surgical outcome. Results: We screened 2622 records and assessed the eligibility of 448 full‐text articles, 246 of which met the inclusion criteria for systematic review: 108 (44%) provided data only on MRI‐neg and 138 (56%) on mixed adult cohorts, for a total of 10.463 MRI‐neg and 7436 MRI‐pos patients. Compared to MRI‐pos, MRI‐neg patients underwent SEEG more frequently (75% vs 54%, p < 0.05), underwent surgery less frequently (73% vs 84%; odds ratio [OR] = 1.14, p < 0.001), and had less favorable outcomes (61% vs 72%, p < 0.05). Clustering identified three classes: MRI‐dominant , typified by consistent reporting of MRI parameters (ORs >3.11, p < 0.001), rater‐expertise (ORs >9.94, p < 0.001), and post‐processing (ORs >3.38, p < 0.03) , as opposed to Limited‐MRI (χ 2 = 41.08, p < 0.001); MRI‐and‐nuclear‐imaging class was typified by use of SEEG (ORs >3.33, p < 0.02). Meta‐analyses showed a 39% gain in diagnostic yield after post‐processing (11.10, 95% confidence interval [CI] 7.45–16.53) and a higher proportion of favorable surgical outcome in MRI‐pos compared to MRI‐neg (75% vs 58%; χ 2 = 19.10, p < 0.001). Time‐based sensitivity analyses did not affect results. Significance: The designation of MRI‐neg is ambiguous, with most studies lacking details on imaging parameters and reader expertise. Given a 39% gain in diagnostic yield, MRI post‐processing should be performed systematically as part of a modern multimodal approach to epilepsy surgery before ascribing MRI‐neg status.
- Open Access
- 24 June 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (12) , e213733
Alterations in Cortical Microstructure, Morphology, and Intrinsic Local Function in Spiking Tissue in Patients With Focal Epilepsy
Epilepsy is increasingly conceptualized as a network disorder, and advancing methods for its diagnosis and treatment requires characterizing both the epileptic generator and related networks. Previous research has highlighted alterations in cortical structure and hemodynamics in epilepsy, but it remains unknown whether these alterations concentrate in areas generating epileptic activity. The aim of this study was to interrogate alterations in microstructure, morphology, and intrinsic local function within and beyond spiking tissue in focal epilepsy, combining multimodal MRI and high-density EEG (HD-EEG). In this cross-sectional study, we recruited patients with focal epilepsy from the Montreal Neurological Institute's epilepsy monitoring unit. Age-matched and sex-matched control participants were recruited from the community. The 3T MRI acquisitions included T1-weighted, diffusion, quantitative T1 relaxometry, and resting-state functional MRI. Open-access processing tools derived cortex-wide maps of morphology and microstructure (cortical thickness, mean diffusivity, and quantitative T1 relaxometry) and intrinsic local function (timescales, connectivity distance, and node strength). Multivariate approaches generated structural and functional alteration scores for each cortical location. Using HD-EEG electrical source imaging, the most prominent spike type was localized and we quantified MRI alterations within spike sources, as well as in proximal and connected networks. We included 25 patients with focal epilepsy (48% female, mean ± SD age = 31.28 ± 9.30 years) and 55 control participants: 30 for imaging feature normalization (50% female, 31.40 ± 8.74 years) and 25 for computing normative connectivity (48% female, 31.04 ± 5.65 years). Regions harboring spike sources showed increased structural MRI alterations compared with the rest of the brain (mean ± SE: 27.98% ± 6.37% vs 17.67% ± 3.32%; t = 2.28; p = 0.036; d = 0.446). Structural compromise extended to all regions with close functional coupling to spike sources, but not to anatomical neighbors. In a modest sample, spiking regions contained more marked alterations in microstructure and morphology than the remaining cortex. There were nevertheless broader network effects, which may relate to a cascading of structural changes to connected cortices. These results underscore the utility of combining quantitative MRI and EEG for characterizing epileptogenic tissue and assessing network effects.
- 24 June 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (12) , e213733
Open AccessAlterations in Cortical Microstructure, Morphology, and Intrinsic Local Function in Spiking Tissue in Patients With Focal Epilepsy
Epilepsy is increasingly conceptualized as a network disorder, and advancing methods for its diagnosis and treatment requires characterizing both the epileptic generator and related networks. Previous research has highlighted alterations in cortical structure and hemodynamics in epilepsy, but it remains unknown whether these alterations concentrate in areas generating epileptic activity. The aim of this study was to interrogate alterations in microstructure, morphology, and intrinsic local function within and beyond spiking tissue in focal epilepsy, combining multimodal MRI and high-density EEG (HD-EEG). In this cross-sectional study, we recruited patients with focal epilepsy from the Montreal Neurological Institute's epilepsy monitoring unit. Age-matched and sex-matched control participants were recruited from the community. The 3T MRI acquisitions included T1-weighted, diffusion, quantitative T1 relaxometry, and resting-state functional MRI. Open-access processing tools derived cortex-wide maps of morphology and microstructure (cortical thickness, mean diffusivity, and quantitative T1 relaxometry) and intrinsic local function (timescales, connectivity distance, and node strength). Multivariate approaches generated structural and functional alteration scores for each cortical location. Using HD-EEG electrical source imaging, the most prominent spike type was localized and we quantified MRI alterations within spike sources, as well as in proximal and connected networks. We included 25 patients with focal epilepsy (48% female, mean ± SD age = 31.28 ± 9.30 years) and 55 control participants: 30 for imaging feature normalization (50% female, 31.40 ± 8.74 years) and 25 for computing normative connectivity (48% female, 31.04 ± 5.65 years). Regions harboring spike sources showed increased structural MRI alterations compared with the rest of the brain (mean ± SE: 27.98% ± 6.37% vs 17.67% ± 3.32%; t = 2.28; p = 0.036; d = 0.446). Structural compromise extended to all regions with close functional coupling to spike sources, but not to anatomical neighbors. In a modest sample, spiking regions contained more marked alterations in microstructure and morphology than the remaining cortex. There were nevertheless broader network effects, which may relate to a cascading of structural changes to connected cortices. These results underscore the utility of combining quantitative MRI and EEG for characterizing epileptogenic tissue and assessing network effects.
- Open Access
In-vivo evidence for increased tau deposition in temporal lobe epilepsy
Temporal lobe epilepsy (TLE), the most common pharmaco-resistant epilepsy in adults, has been linked to structural brain changes extending beyond the mesiotemporal areas. While not traditionally viewed as a neurodegenerative disorder, recent ex-vivo studies have shown elevated levels of misfolded tau protein in TLE. This study investigated tau deposition in TLE patients using the in-vivo PET tracer [18F]MK-6240. We studied 28 TLE patients and 28 healthy controls to assess tau uptake and its relationship with brain connectivity, clinical variables, and cognitive function alongside post-surgical tissue from a subset of patients. Compared to controls, TLE patients exhibited markedly increased [18F]MK-6240 uptake in bilateral superior and medial temporal regions and the parietal cortex, with tau accumulation following regional functional and structural connectivity and cognitive impairment. Immunohistochemistry analysis confirmed variable phosphorylated tau staining in 5/6 operated cases with available specimens. These findings suggest that tau accumulation contributes to cognitive decline observed in TLE, supporting a potential role of tau in epilepsy-related neurodegeneration.
Open AccessIn-vivo evidence for increased tau deposition in temporal lobe epilepsy
Temporal lobe epilepsy (TLE), the most common pharmaco-resistant epilepsy in adults, has been linked to structural brain changes extending beyond the mesiotemporal areas. While not traditionally viewed as a neurodegenerative disorder, recent ex-vivo studies have shown elevated levels of misfolded tau protein in TLE. This study investigated tau deposition in TLE patients using the in-vivo PET tracer [18F]MK-6240. We studied 28 TLE patients and 28 healthy controls to assess tau uptake and its relationship with brain connectivity, clinical variables, and cognitive function alongside post-surgical tissue from a subset of patients. Compared to controls, TLE patients exhibited markedly increased [18F]MK-6240 uptake in bilateral superior and medial temporal regions and the parietal cortex, with tau accumulation following regional functional and structural connectivity and cognitive impairment. Immunohistochemistry analysis confirmed variable phosphorylated tau staining in 5/6 operated cases with available specimens. These findings suggest that tau accumulation contributes to cognitive decline observed in TLE, supporting a potential role of tau in epilepsy-related neurodegeneration.
- Open Access
The use of automated and AI‐driven algorithms for the detection of hippocampal sclerosis and focal cortical dysplasia
In drug‐resistant epilepsy, magnetic resonance imaging (MRI) plays a central role in detecting lesions as it offers unmatched spatial resolution and whole‐brain coverage. In addition, the last decade has witnessed continued developments in MRI‐based computer‐aided machine‐learning techniques for improved diagnosis and prognosis. In this review, we focus on automated algorithms for the detection of hippocampal sclerosis and focal cortical dysplasia, particularly in cases deemed as MRI negative, with an emphasis on studies with histologically validated data. In addition, we discuss imaging‐derived prognostic markers, including response to anti‐seizure medication, post‐surgical seizure outcome, and cognitive reserves. We also highlight the advantages and limitations of these approaches and discuss future directions toward person‐centered care.
Open AccessThe use of automated and AI‐driven algorithms for the detection of hippocampal sclerosis and focal cortical dysplasia
In drug‐resistant epilepsy, magnetic resonance imaging (MRI) plays a central role in detecting lesions as it offers unmatched spatial resolution and whole‐brain coverage. In addition, the last decade has witnessed continued developments in MRI‐based computer‐aided machine‐learning techniques for improved diagnosis and prognosis. In this review, we focus on automated algorithms for the detection of hippocampal sclerosis and focal cortical dysplasia, particularly in cases deemed as MRI negative, with an emphasis on studies with histologically validated data. In addition, we discuss imaging‐derived prognostic markers, including response to anti‐seizure medication, post‐surgical seizure outcome, and cognitive reserves. We also highlight the advantages and limitations of these approaches and discuss future directions toward person‐centered care.
- Open Access
HippoMaps: Multiscale cartography of the human hippocampal formation
The hippocampus has a unique microarchitecture, is situated at the nexus of multiple macroscale functional networks, contributes to numerous cognitive as well as affective processes, and is highly susceptible to brain pathology across common disorders. These features make the hippocampus a model to understand how brain structure covaries with function, in both health and disease. Here, we introduce HippoMaps, an open access toolbox and online data warehouse for the mapping and contextualization of hippocampal data in the human brain (http://hippomaps.readthedocs.io). HippoMaps capitalizes on a novel hippocampal unfolding approach as well as shape intrinsic registration capabilities to allow for cross-subject and cross-modal data aggregation. We initialize this repository with data spanning 3D post-mortem histology, ex-vivo 9.4 Tesla MRI, as well as in-vivo structural MRI and resting-state functional MRI (rsfMRI) obtained at 3 and 7 Tesla, together with intracranial encephalography (iEEG) recordings in epilepsy patients. HippoMaps also contains validated tools for spatial map association analysis in the hippocampus that correct for autocorrelation. All code and data are compliant with community standards, and comprehensive online tutorials facilitate broad adoption. Applications of this work span methodologies and modalities, spatial scales, as well as clinical and basic research contexts, and we encourage community feedback and contributions in the spirit of open and iterative scientific resource development.
Open AccessHippoMaps: Multiscale cartography of the human hippocampal formation
The hippocampus has a unique microarchitecture, is situated at the nexus of multiple macroscale functional networks, contributes to numerous cognitive as well as affective processes, and is highly susceptible to brain pathology across common disorders. These features make the hippocampus a model to understand how brain structure covaries with function, in both health and disease. Here, we introduce HippoMaps, an open access toolbox and online data warehouse for the mapping and contextualization of hippocampal data in the human brain (http://hippomaps.readthedocs.io). HippoMaps capitalizes on a novel hippocampal unfolding approach as well as shape intrinsic registration capabilities to allow for cross-subject and cross-modal data aggregation. We initialize this repository with data spanning 3D post-mortem histology, ex-vivo 9.4 Tesla MRI, as well as in-vivo structural MRI and resting-state functional MRI (rsfMRI) obtained at 3 and 7 Tesla, together with intracranial encephalography (iEEG) recordings in epilepsy patients. HippoMaps also contains validated tools for spatial map association analysis in the hippocampus that correct for autocorrelation. All code and data are compliant with community standards, and comprehensive online tutorials facilitate broad adoption. Applications of this work span methodologies and modalities, spatial scales, as well as clinical and basic research contexts, and we encourage community feedback and contributions in the spirit of open and iterative scientific resource development.
- Open Access
Atypical intrinsic neural timescales in temporal lobe epilepsy
Objective: Temporal lobe epilepsy (TLE) is the most common pharmacoresistant epilepsy in adults. Here we profiled local neural function in TLE in vivo, building on prior evidence that has identified widespread structural alterations. Using resting‐state functional magnetic resonance imaging (rs‐fMRI), we mapped the whole‐brain intrinsic neural timescales (INT), which reflect temporal hierarchies of neural processing. Parallel analysis of structural and diffusion MRI data examined associations with TLE‐related structural compromise. Finally, we evaluated the clinical utility of INT.Methods: We studied 46 patients with TLE and 44 healthy controls from two independent sites, and mapped INT changes in patients relative to controls across hippocampal, subcortical, and neocortical regions. We examined region‐specific associations to structural alterations and explored the effects of age and epilepsy duration. Supervised machine learning assessed the utility of INT for identifying patients with TLE vs controls and left‐ vs right‐sided seizure onset.Results: Relative to controls, TLE showed marked INT reductions across multiple regions bilaterally, indexing faster changing resting activity, with strongest effects in the ipsilateral medial and lateral temporal regions, and bilateral sensorimotor cortices as well as thalamus and hippocampus. Findings were similar, albeit with reduced effect sizes, when correcting for structural alterations. INT reductions in TLE increased with advancing disease duration, yet findings differed from the aging effects seen in controls. INT‐derived classifiers discriminated patients vs controls (balanced accuracy, 5‐fold: 76% ± 2.65%; cross‐site, 72%–83%) and lateralized the focus in TLE (balanced accuracy, 5‐fold: 96% ± 2.10%; cross‐site, 95%–97%), with high accuracy and cross‐site generalizability. Findings were consistent across both acquisition sites and robust when controlling for motion and several methodological confounds.Significance: Our findings demonstrate atypical macroscale function in TLE in a topography that extends beyond mesiotemporal epicenters. INT measurements can assist in TLE diagnosis, seizure focus lateralization, and monitoring of disease progression, which emphasizes promising clinical utility.
Open AccessAtypical intrinsic neural timescales in temporal lobe epilepsy
Objective: Temporal lobe epilepsy (TLE) is the most common pharmacoresistant epilepsy in adults. Here we profiled local neural function in TLE in vivo, building on prior evidence that has identified widespread structural alterations. Using resting‐state functional magnetic resonance imaging (rs‐fMRI), we mapped the whole‐brain intrinsic neural timescales (INT), which reflect temporal hierarchies of neural processing. Parallel analysis of structural and diffusion MRI data examined associations with TLE‐related structural compromise. Finally, we evaluated the clinical utility of INT.Methods: We studied 46 patients with TLE and 44 healthy controls from two independent sites, and mapped INT changes in patients relative to controls across hippocampal, subcortical, and neocortical regions. We examined region‐specific associations to structural alterations and explored the effects of age and epilepsy duration. Supervised machine learning assessed the utility of INT for identifying patients with TLE vs controls and left‐ vs right‐sided seizure onset.Results: Relative to controls, TLE showed marked INT reductions across multiple regions bilaterally, indexing faster changing resting activity, with strongest effects in the ipsilateral medial and lateral temporal regions, and bilateral sensorimotor cortices as well as thalamus and hippocampus. Findings were similar, albeit with reduced effect sizes, when correcting for structural alterations. INT reductions in TLE increased with advancing disease duration, yet findings differed from the aging effects seen in controls. INT‐derived classifiers discriminated patients vs controls (balanced accuracy, 5‐fold: 76% ± 2.65%; cross‐site, 72%–83%) and lateralized the focus in TLE (balanced accuracy, 5‐fold: 96% ± 2.10%; cross‐site, 95%–97%), with high accuracy and cross‐site generalizability. Findings were consistent across both acquisition sites and robust when controlling for motion and several methodological confounds.Significance: Our findings demonstrate atypical macroscale function in TLE in a topography that extends beyond mesiotemporal epicenters. INT measurements can assist in TLE diagnosis, seizure focus lateralization, and monitoring of disease progression, which emphasizes promising clinical utility.
- Open Access
Event‐based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross‐sectional data
Objective: Recent work has shown that people with common epilepsies have characteristic patterns of cortical thinning, and that these changes may be progressive over time. Leveraging a large multicenter cross‐sectional cohort, we investigated whether regional morphometric changes occur in a sequential manner, and whether these changes in people with mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE‐HS) correlate with clinical features.Methods: We extracted regional measures of cortical thickness, surface area, and subcortical brain volumes from T1‐weighted (T1W) magnetic resonance imaging (MRI) scans collected by the ENIGMA‐Epilepsy consortium, comprising 804 people with MTLE‐HS and 1625 healthy controls from 25 centers. Features with a moderate case–control effect size (Cohen d ≥ .5) were used to train an event‐based model (EBM), which estimates a sequence of disease‐specific biomarker changes from cross‐sectional data and assigns a biomarker‐based fine‐grained disease stage to individual patients. We tested for associations between EBM disease stage and duration of epilepsy, age at onset, and antiseizure medicine (ASM) resistance.Results: In MTLE‐HS, decrease in ipsilateral hippocampal volume along with increased asymmetry in hippocampal volume was followed by reduced thickness in neocortical regions, reduction in ipsilateral thalamus volume, and finally, increase in ipsilateral lateral ventricle volume. EBM stage was correlated with duration of illness (Spearman ρ = .293, p = 7.03 × 10−16), age at onset (ρ = −.18, p = 9.82 × 10−7), and ASM resistance (area under the curve = .59, p = .043, Mann–Whitney U test). However, associations were driven by cases assigned to EBM Stage 0, which represents MTLE‐HS with mild or nondetectable abnormality on T1W MRI.Significance: From cross‐sectional MRI, we reconstructed a disease progression model that highlights a sequence of MRI changes that aligns with previous longitudinal studies. This model could be used to stage MTLE‐HS subjects in other cohorts and help establish connections between imaging‐based progression staging and clinical features.
Open AccessEvent‐based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross‐sectional data
Objective: Recent work has shown that people with common epilepsies have characteristic patterns of cortical thinning, and that these changes may be progressive over time. Leveraging a large multicenter cross‐sectional cohort, we investigated whether regional morphometric changes occur in a sequential manner, and whether these changes in people with mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE‐HS) correlate with clinical features.Methods: We extracted regional measures of cortical thickness, surface area, and subcortical brain volumes from T1‐weighted (T1W) magnetic resonance imaging (MRI) scans collected by the ENIGMA‐Epilepsy consortium, comprising 804 people with MTLE‐HS and 1625 healthy controls from 25 centers. Features with a moderate case–control effect size (Cohen d ≥ .5) were used to train an event‐based model (EBM), which estimates a sequence of disease‐specific biomarker changes from cross‐sectional data and assigns a biomarker‐based fine‐grained disease stage to individual patients. We tested for associations between EBM disease stage and duration of epilepsy, age at onset, and antiseizure medicine (ASM) resistance.Results: In MTLE‐HS, decrease in ipsilateral hippocampal volume along with increased asymmetry in hippocampal volume was followed by reduced thickness in neocortical regions, reduction in ipsilateral thalamus volume, and finally, increase in ipsilateral lateral ventricle volume. EBM stage was correlated with duration of illness (Spearman ρ = .293, p = 7.03 × 10−16), age at onset (ρ = −.18, p = 9.82 × 10−7), and ASM resistance (area under the curve = .59, p = .043, Mann–Whitney U test). However, associations were driven by cases assigned to EBM Stage 0, which represents MTLE‐HS with mild or nondetectable abnormality on T1W MRI.Significance: From cross‐sectional MRI, we reconstructed a disease progression model that highlights a sequence of MRI changes that aligns with previous longitudinal studies. This model could be used to stage MTLE‐HS subjects in other cohorts and help establish connections between imaging‐based progression staging and clinical features.
- Open Access
- 29 November 2021
- Published by Oxford University Press (OUP) in Brain
- Vol. 145 (3) , 897-908
Decomposing MRI phenotypic heterogeneity in epilepsy: a step towards personalized classification
In drug-resistant temporal lobe epilepsy, precise predictions of drug response, surgical outcome and cognitive dysfunction at an individual level remain challenging. A possible explanation may lie in the dominant ‘one-size-fits-all’ group-level analytical approaches that does not allow parsing interindividual variations along the disease spectrum. Conversely, analysing inter-patient heterogeneity is increasingly recognized as a step towards person-centred care. Here, we used unsupervised machine learning to estimate latent relations (or disease factors) from 3 T multimodal MRI features [cortical thickness, hippocampal volume, fluid-attenuated inversion recovery (FLAIR), T1/FLAIR, diffusion parameters] representing whole-brain patterns of structural pathology in 82 patients with temporal lobe epilepsy. We assessed the specificity of our approach against age- and sex-matched healthy individuals and a cohort of frontal lobe epilepsy patients with histologically verified focal cortical dysplasia. We identified four latent disease factors variably co-expressed within each patient and characterized by ipsilateral hippocampal microstructural alterations, loss of myelin and atrophy (Factor 1), bilateral paralimbic and hippocampal gliosis (Factor 2), bilateral neocortical atrophy (Factor 3) and bilateral white matter microstructural alterations (Factor 4). Bootstrap analysis and parameter variations supported high stability and robustness of these factors. Moreover, they were not expressed in healthy controls and only negligibly in disease controls, supporting specificity. Supervised classifiers trained on latent disease factors could predict patient-specific drug response in 76 ± 3% and postsurgical seizure outcome in 88 ± 2%, outperforming classifiers that did not operate on latent factor information. Latent factor models predicted inter-patient variability in cognitive dysfunction (verbal IQ: r = 0.40 ± 0.03; memory: r = 0.35 ± 0.03; sequential motor tapping: r = 0.36 ± 0.04), again outperforming baseline learners. Data-driven analysis of disease factors provides a novel appraisal of the continuum of interindividual variability, which is probably determined by multiple interacting pathological processes. Incorporating interindividual variability is likely to improve clinical prognostics.
- 29 November 2021
- Published by Oxford University Press (OUP) in Brain
- Vol. 145 (3) , 897-908
Open AccessDecomposing MRI phenotypic heterogeneity in epilepsy: a step towards personalized classification
In drug-resistant temporal lobe epilepsy, precise predictions of drug response, surgical outcome and cognitive dysfunction at an individual level remain challenging. A possible explanation may lie in the dominant ‘one-size-fits-all’ group-level analytical approaches that does not allow parsing interindividual variations along the disease spectrum. Conversely, analysing inter-patient heterogeneity is increasingly recognized as a step towards person-centred care. Here, we used unsupervised machine learning to estimate latent relations (or disease factors) from 3 T multimodal MRI features [cortical thickness, hippocampal volume, fluid-attenuated inversion recovery (FLAIR), T1/FLAIR, diffusion parameters] representing whole-brain patterns of structural pathology in 82 patients with temporal lobe epilepsy. We assessed the specificity of our approach against age- and sex-matched healthy individuals and a cohort of frontal lobe epilepsy patients with histologically verified focal cortical dysplasia. We identified four latent disease factors variably co-expressed within each patient and characterized by ipsilateral hippocampal microstructural alterations, loss of myelin and atrophy (Factor 1), bilateral paralimbic and hippocampal gliosis (Factor 2), bilateral neocortical atrophy (Factor 3) and bilateral white matter microstructural alterations (Factor 4). Bootstrap analysis and parameter variations supported high stability and robustness of these factors. Moreover, they were not expressed in healthy controls and only negligibly in disease controls, supporting specificity. Supervised classifiers trained on latent disease factors could predict patient-specific drug response in 76 ± 3% and postsurgical seizure outcome in 88 ± 2%, outperforming classifiers that did not operate on latent factor information. Latent factor models predicted inter-patient variability in cognitive dysfunction (verbal IQ: r = 0.40 ± 0.03; memory: r = 0.35 ± 0.03; sequential motor tapping: r = 0.36 ± 0.04), again outperforming baseline learners. Data-driven analysis of disease factors provides a novel appraisal of the continuum of interindividual variability, which is probably determined by multiple interacting pathological processes. Incorporating interindividual variability is likely to improve clinical prognostics.